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Receptors for the Fc portion of IgG (FcyR)' provide a link between humoral and
cellular immune response by targeting antibody/antigen complexes to effector cells.
Crosslinking of these receptors on macrophages results in a wide array of cellular
responses, which include phagocytosis, secretion of reactive oxygen intermediates,
and lysosomalhydrolases, andultimately mediates antibody-dependent cellular cytox-
icity (ADCC) (1). Studies on mouse macrophages have defined three distinct FcyRs:
alow-affinity, trypsin-resistant receptor that binds IgGl/IgG2b (2, 3), ahigh-affinity
trypsin-sensitive receptor for monomeric IgG2a (4), and a receptor for IgG3 (5).
Characterization of the IgGl/IgG2b FcyR has been facilitated by the mAb 2.4G2,
which blocks ligand binding to this receptor (6). In addition to its expression on
macrophages, this FcyR is expressed on lymphocytes, where it displays broaderligand
specificities, binding IgG1, IgG2b, as well as IgG2a (7). Its role on lymphocytes is
not well defined but it is presumed to be involved in immune regulation (8).
This functional heterogeneity of the IgG2b/IgG1 FcyR has been addressed at the
molecular level by the characterization of two genes that encode this receptor, re-
ferred to as FcyRa and FcyRR(9-11). These genes encode predicted transmembrane
proteins with nearly identical extracellular domains, while differing completely in
the transmembrane and cytoplasmic domains. Alternative splicing of the (3 gene
results in two transcripts ((31 and 02) that differ in the cytoplasmic domain. The
FcyRa transcript is expressed only in macrophages, while the FcyR(3 transcript is
found in both macrophages and lymphocytes. Thus, the functional diversity dis-
played by this receptor on different cell types may result from the structural hetero-
geneity encoded in these two genes and their alternative transcripts.
To begin to address the role of this structural heterogeneity in mediating different
FcyR functions, we have studied the contribution of FcyRa and -Q gene expression
for two phenotypes, ligand specificity and macrophage activation. Throughthe trans-
fection of these genes into FcyR negative cells, the contribution of different struc-
tural domains was assessed in determining ligand specificity. Further, we have iso-
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lated a mutant cell line derived from J774, which expresses only FcyR-a . This cell
line is used as a model to investigate the function of the macrophage-specific FcyR-
a. By treating .those cells, as well as other macrophage-like cell lines and resident
mouse peritoneal macrophages, with IFN-y, we have assessed the role of these two
genes in the process of macrophage activation. Treatment of macrophages with this
lymphokine has been shown to result in increased phagocytosis of IgG-opsonized
SRBC (12) and stimulation of the FcyR-mediated respiratory burst and ADCC (13).
In this study we demonstrate the selective expression of FcyR-a induced by IFN-y
in these cell lines, which concommitantly become competent in the phagocytosis
of antibody-coated particles. These data suggest that it is FcyR-a that plays a major
role of binding antibody/antigen complexes and mediating phagocytosis by macro-
phages.
Materials and Methods
Cell Culture.
￿
The macrophage-like cell lines RAW 264.7 (14)J774 (15), and P388D1 (16)
were grown in alpha-modified MEM (a-MEM) supplemented with 10% FCS (HyClone
Laboratories, Logan, UT) heat inactivated at 56°C for 30 min, 100 U/ml penicillin, and
100 lag/ml streptomycin. Primary cultures of mouse peritoneal macrophages were established
from pathogen-free female ICR mice (Charles River Breeding Laboratories, Kingston, NY)
weighing 25-30 g as previously described (17) . Cells were cultured overnight before use in
a-MEM containing 10% FCS.
Gene Transfer.
￿
Coding sequences of the various cDNAs were cloned into the Smal site of
the eukaryotic expression vector pcEXV3 (18). Transcription of the cloned sequences was
under the control of the SV40 early promoter. LtK- cells were plated 24 h before transfec-
tion at 2 x 105 cells per 60-mm petri dish. The next day, the medium was removed and dis-
carded, and the monolayers were washed twice with PBS. The cells were then incubated with
serum-free DME containing DEAE-dextran (mol wt, 2 x 10") at a concentration of 150
~ig/ml along with the plasmid DNA containing FcyR sequences at 8-15 Ag/ml. After a 16-h
exposure of the cultures to the DNA at 37°C in a C02 incubator, the cells were washed once
with PBS and fed with a-MEM supplemented with 10% FCS. At -60 h after the cultures
were transfected, the cells were assayed for expression of surface FcyRs.
B78H1 cells were plated 24 h before transfection at 2 x 105 cells per 100-mm petri dish.
High-molecular weight human DNA (19 wg) was mixed with pGCcos3neo (500 ng), the recom-
binant expression vector (1 .5 ug) as described above, and was allowed to form calcium phos-
phate precipitates. 1 ml of precipitate was added per dish and incubated at 37° for 16 h.
The medium was removed and replaced with selective medium containing 1 mg/ml ofGeneticin
(G418, Gibco, Grand Island, NY). Plates were refed every 2 d and resistant colonies were
screened at -10 d by rosetting with human erythrocytes conjugated with the mAb 2AG2
(19). Alternatively, screening was performed with SRBC opsonized with rabbit antiserum
to SRBC .
Preparation ofOpsonizedErythrocytes, Rosetting andPhagocytosisAssay.
￿
Sheep erythrocytes (Gibco)
were first derivatized with the hapten TNP, as previously described (20). They were then
incubated with the monoclonal anti-DNP U-7-6 (IgGl), U-7-27-1 (IgG2a), or U-12-5-1
(IgG2b) (gifts of Dr. Zelig Eschar, Weitzmann Institute, Israel) Opsonized SRBC were in-
cubated with the transfected cell lines for 30 min at room temperature and then washed ex-
tensively with PBS. Rosetting for phagocytosis studies was performed with SRBC opsonized
with rabbit serum to SRBC (Cappel Laboratories, Malvern, PA) at a non-agglutinating titer
of antibody. After a 90-min incubation at 37°C, the macrophage cells were washed in PBS
and then again in distilled water to hypotonically lyse extracellular rosetted SRBC. The cells
were then fixed in 0.25% glutaraldehyde and were photographed.
IFN-y Induction.
￿
The murine IFN-y used in this study was highly purified recombinant
protein synthesized in Escherichia coli and was generously provided by Genentech. The mouse
IFN-y had a specific activity of 1 .9 x 10' U/mg. Highly purified mouse IFN-a and IFN-Rwere purchased from Lee-BioMolecular Research Laboratories, Inc., San Diego, CA. The
mouse IFN-a had a specific activity of 1.7 x 10' International Reference Units per mg, and
the mouse IFN-R had a specific activity of 5.3 x 10' International Reference Units per mg.
The macrophage linesJ774, RAW 264.7, and P388D1 were inducedjust before confluence
in their regular cell growth media with either 200 U/ml IFN-y or 500 U/ml IFN-a or -(3.
Resident mouse peritoneal macrophages were incubated in 100-mm culture dishes for 5 h
after isolation. After attachment, the cells were washed twice with PBS and then incubated
with 200 U/ml IFN-y.
Iodination and Binding Studies.
￿
Purified IgsIgG1 (MOPC 21, Miles Laboratories Inc., Naper-
ville, IL), IgG2a (UPC 10, Bionetics Laboratory Products, Kensington, MD), IgG2b (MOPC
195, Miles Laboratories Inc.), IgG3 (FLOPC 21, Bionetics Laboratory Products), and IgA
(MOPC 315, Bionetics Laboratory Products) were iodinated using50 Ag of each protein and
1.0 MCi of ' 25INa (Amersham Corp., Arlington Heights, IL) using Iodo-Beads (Pierce
Chemical Co., Rockford, IL) as described (21). B78-FcyR-transferred cell lines were plated
in 60-mm culture dishes and incubated with either monomeric 1251-labeled Igs or heat ag-
gregated Igs that were prepared by mixing an excess of nonlabeled Ig (1 mg/ml) with the
corresponding '251-labeled protein for 45 min at 65'C. After incubation, the cells were
washed three times with PBS and then solubilized with IN NaOH for gamma counting.
For direct binding studies on macrophage cell lines, 2AG2 was iodinated as above and
incubated in suspension with 10`' cells per ml for 90 min at VC. Cells were washed by
pelleting and resuspension, and bound radioactivity was determined by gamma counting.
Indirect binding was performed with nonlabeled 2AG2 and assayed with '211-labeled affinity-
purified goat anti-rat IgG (Cappel Laboratories).
Northern Blot Analysis.
￿
RNA was isolated by the guanidine isothiocyanate procedure and
was poly(A) selected (22). Poly (A') RNA was fractioned on a 1% agarose gel containing
2.2 M formaldehyde andwastransferred to nitrocellulose (23). Nitrocellulose filters were hy-
bridized at 42'C for 16 h in a solution containing 50% formamide, 10% dextran sulfate,
5 x SSC (1 x SSC is 0.15 M sodium chloride, 0.015 M sodium citrate), 1 x Denhardt's (0.02
polyvinyl-pyrrolidone, 0.02% Ficoll, and 0.02% BSA), and 200 wg/mlsonicated herring sperm
DNA. The filters were washed at 50'C in 0.1 x SSC containing 0.1% SDS and exposed at
-70'C to Kodak XAR film in the presence of intensifying screen (Cronex LightningPlus).
Results
Expression ofFcyR-a andFcyR-l3 by Transfection in FcyR-negative Cell Lines.
￿
The struc-
tural requirements for ligand binding of the FcyRa and -R molecules was deter-
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01, and FcyR-a are cDNA clones de-
rivedfrom lymphocyte andmacrophage
libraries (9). All cDNA were cloned into the expression vector pcEXV3 for transfection experi-
ments as described in Fig. 2. The structural relationships among these FcyR cDNA are sche-
matically illustrated, demonstrating conservation of the E-C among all the transcripts, diver-
gence of the S, TM, and C domains, and the alternative splicing relationship of R1 and 02 in
the cytoplasmic domain.
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mined by expression of cDNA for a and 0 in FcyR negative cell lines. Expression
ofthese cDNA sequences (Fig. 1) was achieved by inserting their entire coding se-
quencesintoan expression vector (pcEXV3)(18) in which the SV40early promoter
is used to achieve transcription of the heterologous sequences. We have previously
shown that the transfection ofFcyR-ß2 resulted in the establishment of stable lines
that avidly bound SRBC opsonized with rabbit IgG (9). Furthermore, a complete
cytoplasmicdomain is apparently unnecessary forthe surfaceexpressionofthe FcyR0
gene product, as determined by the expression ofa truncated form of the FcyR0I
(data not shown). FcyR-a and -ß share 95% identity in their extracellular domain
(9) with no homology in either the serine/threonine rich region amino terminal to
the transmembrane domain, the transmembrane domain, or the cytoplasmic do-
main. To determine thecontribution ofthesestructural differencestoligand binding,
we have compared the FcyRa and -0 gene products as expressed by transfection of
FcyR negative cells.
Expression of FcyRa was achieved in mouse LtK- cells and COS (monkey
kidney) cells and was detected by rosetting with IgG-opsonized SRBC 60 h after
introduction of these genes in a transient expression system (not shown). The fre-
quency oftransient surface expression of the transfected FcyR-a was observed to be
lowerthan that observed for FcyR0, although the intensity ofrosetting on an FcyR-
a positive cell was the same as was observed for FcyR-0 (see Fig. 2). This difference
in transfection frequency of the FcyR-a and -0 constructs may result from the con-
tribution of 3' untranslated sequences of FcyRa (R. Weinshank, unpublished ob-
servations). Both receptors were inhibitedintheir ability to bind ligand by the mAb
2ÁG2 (not shown), as predicted by their highly homologous extracellular domains
(9). Thus, the structural requirements for immune complex binding are encoded
in either FcyR-a or -0 molecules alone.
IgG Subclass-specific Binding to FcyR-a and -ß .
￿
Lymphocytes, which express FcyR-
0 only, have been reported to bind mouse IgG1, 2a, and 2b immune complexes, (7)
while macrophages, which express FcyR-a and -0, display a more restricted binding
with specificity for IgG1 and 2b (6). To determine ifthis observed difference in IgG
immunecomplex bindingtothe FcyR is encoded by the structural differences found
in FcyR-a and -0, the subclass specificity ofIgG immune complex binding was de-
termined on the transfectants expressing these molecules. Mouse mAbs ofdefined
subclasses specific for DNP were reacted with SRBC derivitized with TNP (20).
LtK- cells transiently transfected with FcyR-a or -0 constructs were assayed for
FIGURE 2.
￿
Subtype specificity ofFcyR-a and FcyR-ß2 transiently expressed in transfected LtK-
cells. An 1,100-bp Hinfl-Ball fragment derived from the FcyR-a clone and a 1,300-bp Pstl frag-
ment derived from the FcyR-ß2 clone (9) were cloned into the Smal site of the eukaryotic expres-
sion vector pcEXV3. The recombinant plasmids were transfected onto mouse LtK- cells by
the DEAE-dextran technique (45) using 3 ug/ml of pcEXV3-p2 and 15 Wg/ml of pcEXV3-a .
After a60-h incubation, the cells were assayed for isotype specificity using subclass-defined mAbs
directed against the hapten DNP. SRBC were coupled to TNP(20) andincubated with the indi-
cated mAb. The opsonized RBC were incubated with the transfected Ltk- cells for 30 min at
room temperature and then washed several times with PBS. Thecells were then fixed with 0.25%
glutaraldehydeandscored for rosette formation. Identical results were obtained in COS(monkey
kidney) cells; however, transfection of a 1,300-bp Pst I fragment of FcyRa in pcEXV3 (9) did
not result in observable surface expression of FcyRa protein in Ltk- or COS cells, nordid ex-
pression of the 1,100-bp Hinf-Bal fragment result in expression of FcyR-a in B78H1 melanoma
cells.1914
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FIGURE 3 .
￿
IFN inducibility and specificity of FcyR-a and FcyR-0 transcripts in macrophage-
likecell lines . Macrophage cell lines RAW 264 .7, J774a, and P388D1 were maintained in culture
as described in Materials and Methods. The cells were treated with 200 U/ml of IFN-y for
18 h after which RNA blots were prepared as described and hybridized under stringent condi-
tions either with the FcyRa-specific probe (A) or the FcyR-R-specific probe (B) . RNA was also
isolated from J774a cells that had been treated with 500 U/ml of either IFN-a or IFN-p for
18 h (C) . The ribosomal RNA markers are indicated . Poly(A)' RNA levels were normalized
by reprobing the blots with GPDH .
binding to these subclass specificimmune complexes . Binding wasobserved to IgG1-,
IgG2a-, and IgG2b-coated SRBC forboth FcyRa and -R transfectants (Fig. 2), while
no binding was observed for IgG3 or monomeric IgG (not shown) . The binding
of these IgG subclasses was inhibitable by the FcyR-specific mAb2AG2 (not shown) .
In addition to an identical specificity of binding, there were no differences in the
numbers ofboundSRBC foreither receptor. Thus, the structural differences found
between a and Q do not contribute to differences in ligand specificity when expressed
on heterologous cells .
Identical results were obtained in stable transfectants of B78H1 melanoma cells
expressing the FcyR(32 molecule. As wasobserved in the transient assays, IgG mono-
meric binding wasnotobserved for this molecule (not shown), while binding ofheat-
aggregated IgG1, 2a, and 2b was observed . Again, similar to what was shown in
the transientexpression studies (Fig . 2), rosetting of this stable line with IgGl-, 2a-,WEINSHANK ET AL .
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FIGURE 4 . Time course for FcyR-a
mRNA induction by IFN-y in J774a
cells . J774a cells were treated with 200
U/ml ofIFN-y for the indicated times,
after which RNA blots were prepared
as described and hybridized under
stringent conditions with the FcyR-a-
specific probe . Quantitation of the
RNA blot was performed by densitom-
eter scanning (fold induction = den-
sitometer units induced/densitometer
units uninduced) after normalization
with the constitutive probe GPDH .
and 2b-coated SRBC was observed (not shown) . No binding was detected for heat-
aggregated IgG3 or IgA, consistent with the previous observation (5) that these iso-
types bind to separate Fc receptors .
Differential Expression of FcyR-a and -ß in Macrophage Activation .
￿
To investigate the
contribution ofa and ß gene expression to different FcyRmediated phenotypes, we
have characterized theirexpression and regulation in macrophage activation . Previous
studieshave defined IFN-y as a macrophage activating factor (MAF [25, 26]) . Three
macrophage lines were used in this study. Two of the cell lines, RAW 264.7 (14) and
P388D1 (16), have previously been described .A third cell line is a spontaneous mu-
tant derived from J774 (15) . This cell line differs from its previous description (9)
in that it no longer expresses FcyRß . This cell line is designated J774a. Treatment
with mouse IFN-y at aconcentration of 200 U/ml for 16h induced the FcyRamRNA
from undetectable levels in RAW 264.7 cells while inducing FcyR-a mRNA -25-
fold inJ774a cells (Fig. 3 A) . The macrophage-like cell line P388D1 expressed high
levels ofFcyRa and -ßmRNA constitutively that were unaffected by IFN-y . RAW
cells expressed low levels of FcyR-ß mRNA that were similarly unaffected by IFN-y,
whileJ774a cells could not be induced to express detectable FcyRß mRNA (Fig .
3 B) . Induction of FcyRamRNA levels inJ774a was specific for IFN-y and could
not be demonstrated with either mouse IFN-a or -ß at theconcentrations tested (Fig .
3 C) . A time course for induction of FcyR-a mRNA in J774a cells was performed
and demonstrated a threefold increase in steady-state message levels as early as1916
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FIGURE 5 .
￿
FcyR mRNA levels in resting and IFN-y-activated mouse peritoneal macrophages .
Primary cultures of peritoneal macrophages were treatedwith 200 U/ml of IFN-y for 18 h, after
whichRNAwas isolated from controlandtreated cells by the guanidine isothiocyanate procedure .
TotalRNA (10 pg)was fractionated on agarose-formaldehyde gels, transferred to nitrocellulose,
and hybridized under stringent conditions either with the FcyR-a-specific probe, the FcyR-p-
specific probe, or a cDNA probe forthe class II A-a murine Ia heavy chain (24) . Hybridization
to a larger RNA transcript (N3.0 kb) with the 3' FcyR-0 gene-specific probe has been observed
to be ofvariable intensity in macrophage-like cell linesand mayrepresent either apgene precursor
transcript or crosshybridization to another related gene transcript . RNAlevels were normalized
by both ethidium bromide staining and reprobing the blots with a cDNA probe against glycer-
aldehyde 3-phosphate dehydrogenase, an enzyme that is not modulated by IFN (34) . Quantita-
tion of theRNA blot was performed by densitometer scanning.
4 h, with maximal induction of N25-fold at 16 h, afterwhich adecline in these levels
was observed (Fig . 4) . The expression of FcyRa was then maintained at a 5-7-fold
increase after 50 h of continuous IFN-y treatment .
To evaluate the significance of the FcyRa induction in these macrophage-like cell
lines, the effect ofIFN-yon FcyRa and -a gene expression in mouse peritoneal mac-
rophages was determined at 18 h ofIFN-y stimulation, the peak of the response ob-
served inJ774a cells . Both FcyRa and FcyR-0 mRNA were abundantly expressed
in these cells (Fig. 5), with no modulation apparent by IFN-y on FcyRa expression,
when normalized with a constitutive glycolytic enzyme probeGPDH . However, in
the presence of IFN-y, FcyR (3mRNA was decreased -10-fold. Class II murine major
histocompatibility AamRNA (24) was induced 17-fold by IFN-y in mouse perito-
neal macrophages, indicating that IFN-y-Rs were present and functional . Thus, the
IFN-y-activated peritoneal macrophage resembles the IFN-y-stimulated J774a and
RAW cell lines in expressing high levels of Fcy-a mRNA and little or no FcyR-0
mRNA . Similarly, thioglycollate-elicited macrophages demonstrate high levels ofWEINSHANK ET AL.
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TABLE I
Binding of 1251-2.462 to IFN-y-induced Macrophage-like Cell Lines
The macrophage-like cell lines were treated with 150 U/ml of IFN-y for either 48 (RAW 264.7)
or 96 h (J774a), after which they were removed from their culture flasks so that control and
IFN-y-treated cells could be normalized for cell number. RAW 264.7 cells (1007ml) andJ774a
cells (4 x 10''/ml) were then incubated with 1261-2.4G2 along with the indicated nonlabcled
Ig for 90 min at 4°C. The cells were washed three times in PBS by pellcting and resuspcnsion
after which bound radioactivity was determined by gamma counting. Values are the mean ± SD
for "'I-2.4G2 binding, n = 3.
FcyR-a mRNAand little orno FcyR(3mRNA as determined by RNA in situ studies
(Kirsch, I. R. and J. Ravetch, unpublished results).
IFN-y Induces Surface Protein Expression and Ligand Binding Activity of the FcyR-a on
J774a Cells. InductionofFcyRa RNAby IFN-yresults in increasedlevels ofFcyR-a
protein, as demonstrated by the binding of1251-2.4G2 to the macrophage linesJ774a
and RAW (Table I). Both celllines had detectablelevels ofthe 2AG2 epitope, which
was induced by IFN-y. After subtraction of the nonspecific binding components,
induction of the 2AG2 epitope was 4.5-fold on J774a cells and 5.2-fold on RAW
cells (Table I). Identical results were obtained with 1251-Fab 2AG2, indicating that
the induction was not a result of2AG2 bindingby its Fc portion to IFN-stimulated
cells (not shown). In addition, similar results were obtained using FcyRa-specific
antiseramade against synthetic peptides corresponding to the cytoplasmic domain
ofFcyRa (R. Weinshank, R. Schreiber, andJ. C. Unkeless, unpublished observa-
tions). IFN-y has been shown to result in increased expression of many proteins
specifically induced by this lymphokine (27). To rule out an increase in 2AG2 binding
as a result of nonspecific changes in IFN-y-treated cells, indirect binding studies
were also performed onJ774a cells using a panel ofmAbs against a varietyofmac-
rophage surface markers (Fig. 6). A control mAb against a cytoplasmic enzyme,
ornithine decorboxylase, exhibited no binding in the absence orpresence of IFN-y.
Neither the Mac-1 determinant nor a protein modulated by parathyroid hormone
(p150) was inducible by IFN--f on these cells. Class II cell surface proteins (1a) and
thelymphocyte function-associated protein (LFA-1) were inducible by IFN-y as pre-
viously reported (28-30). In addition, the protease-sensitive cell-surface glycopro-
tein found on macrophages (F4/80) was also inducible by IFN-y. Surprisingly, the
Thy-1 determinant was significantly induced by IFN-y on J774a cells from unde-
tectable levels.
Finally, to determine ifthe induction ofFcyR-a mRNA and protein results in in-
creased binding ofIgG immune complexes toJ774a cells, rosetting ofIgGl-coated
erythrocytes toJ774a cells was performed. As seen in Fig. 7, binding was induced
by IFN-y and was inhibitable by mAb 2AG2. The same observation wasmade using
J774a cells RAW 264.7 cells
Nonlabeled Ig Control IFN-y Control IFN-y
No addition 12,069 t 538 39,152 ± 2,711 16,546 ± 1,018 64,755 ± 3,806
2AG2 4,413 f 415 4,166 ± 287 5,263 ± 329 5,487 t 717
(10 ug/ml)
IgG2a 12,061 ± 1,093 38,231 ± 3,456 14,848 ± 1,286 56,927 ± 2,657
(10 gg/ml)1918
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FIGURE 6 .
￿
Comparison of FcyRainductionby
IFN-y with other cell-surface markerson J774a
cells . J774a cells were cultured in the presence
(48 h) or absence of 200 U/ml IFN-y . The cells
were then removed from their flasks and normal-
ized for cell number by coulter counting. 10 6
cells from control or IFN-y treated culture flasks
were incubated with ratmAbs with the following
specificities : ornithine decarboxylase, (35), Thy-
1 (36), F4/80 (37), p150-parathyroid hormone
modulated protein (38), lymphocyte function as-
sociated (LFA-1) (39), class II surface molecule
(1a) (40), macrophage surface marker (Mac-1)
(41), and FcyR (2.4G2) (6). The cells were in-
cubated for 90 min at 4°C in an end-over-end
mixerand then washed three times inPBS . Bound
antibody was detected with affinity purified goat
anti-rat IgG labeled with 1251 . After incubation,
the cellswere again washed threetimesandbound
radioactivity was detected by gamma counting .
IgG2b-coated erythrocytes (data not shown), thereby establishing the FcyR-a pro-
tein induced by IFN-y on these cells to be a functional FcR .
IFN-y Induction ofPhagocytosis .
￿
IFN-y has previously been shown to activate mac-
rophages leading to a variety ofFcyR-mediated effector functions such as phagocy-
tosis, the oxidative burst, andADCC (13) . In the absence of IFN-y, J774a andRAW
cells exhibited a minimal level of phagocytosis despite abundant rosettingwith IgG-
oponized SRBC (Fig . 8) . P388D1 cells, however, were actively phagocytic in the
absence ofIFN-y . After treatment with 200 U/ml ofIFN-y for 18 h, a dramatic in-
crease of phagocytosis inRAW andJ774a cells was observed (Fig. 8) . This increase
was reflected both in the number of macrophages within the population that had
engulfed opsonized SRBC, as well as the number of protected SRBC per macro-
phage . P388D1 cells were actively phagocytic in the presence of IFN-y, but not
significantly differentfrom the untreated P388D1 cells . Thus, the induction ofphago-
cytosis in these cells parallels the induction of one of the two FcyR genes, FcyR-a .
Discussion
FcyRs occupy a central role in both the execution of cellular immune reactions
andthe coordination between humoral and cellularimmune response systems . The
diversity ofmouse IgG subclasses is reflected in a diversity ofIgG FcR. In addition
to the existence ofmultiple receptors for different subclasses, FcyRs can distinguish
between monomeric and immune-complexed Ig (4) . The cell type specificity and
differences in the functional domains of these receptors suggest that different FcR-
mediated phenotypes may be triggered on specific cells in response to a common
FIGURE 7 .
￿
IFN-y induction ofligand binding on J774aand competition with2ÁG2 . J774a cells
were treated with 200 U/ml IFN-y for 48 h, after which control (untreated) and treated cells
were preincubated withmAb 2ÁG2 for 30 min at 37°C. TNP-SRBC opsonized with IgG1 were
then incubated for 30 min at room temperature and then washed several times in PBS . The cells
were then fixed in 0.25% glutaraldehyde and photographed .WEINSHANK ET AL .
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FIGURE 8 .
￿
Effect of IFN-y on phagocytic ability of mouse macrophage-like lines . The indicated
cell lines, either treated with 200 U/ml IFN-y for 48 hor untreated, were incubated with SRBC
opsonized with anti-SRBC rabbit IgG at 37°C for 1 h, washed three times with PBS, andchecked
for rosetting. All lines demonstrated positive rosetting and were then washed rapidly three times
with distilledH2O to lyse external SRBC, fixed in glutaraldehyde and photographed. IFN-y treat-
ment dramatically increases phagocytosis in RAW andJ774a lines, as determined by counting
internalized SRBC . P388DI, in contrast, demonstrated little or no change in internalized SRBC .WEINSHANK ET AL.
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ligand. The recent cloning of two FcyR genes and their transcripts (9-11) has facili-
tated the analysis of this complex receptor system. To begin to define the functional
consequences of the structural complexity of this system, we have expressed cDNA
encoding FcyR-a, -01, and -R2 molecules by transfection of these clones into FcyR
negative cell lines. We show here that both FcyRa and FcyRR cDNA expressed in
FcyR negative lines are capable of the binding of IgG immune complexes, and that
the requirements forligand binding ofeach of the respective receptors are therefore
encoded in a single gene. Both molecules bear the 2AG2 epitope and are inhibited
in their binding to ligand by this mAb. These FcyRs function as low-affinity binding
receptors with a specificity not only forIgG1 and IgG2b, butalso IgG2a. This broader
specificity found for the FcyR molecules when analyzed by transfection is consistent
with the observed specificity of this FcyR on lymphocytes (which express only FcyRO)
(7), and the behavior of this receptor after purification from macrophages (31). We
propose that FcyR-a functions on macrophages in vivo with this specificity as well.
The presence of the high-affinity IgG2a receptor on macrophages may compete for
the binding of immune complexes of this subclass and result in a more restricted
subclass specificity when analyzed by 2.4G2-inhibitable bindingon macrophage lines.
This is shown to be the case on resting mouse peritoneal macrophages. Without
IFN-y treatment, 2AG2 can almost completely block IgG2a binding. In the pres-
ence of IFN-y, which induces the high-affinity receptor (32, 33), 2AG2 canno longer
block IgG2a binding(data not shown). Similarly, thioglycollate-elicited macrophages
possess a greater number of IgG2a receptors that are not competed by mAb 2AG2
(not shown).
Since IFN-yhas previously been shown to induce the high-affinity FcyR, the selec-
tive induction of FcyRa by IFN-y observed in RAW andJ774a cells raised the pos-
sibility that this molecule may be a component of the high-affinity IgG2a receptor.
Three observations suggest that this is not the case. First, mouse LtK- cells trans-
fected with FcyR-a are incapable of binding monomeric IgG2a. Second, IgG2a
binding was observed in RAW cells in the absence of IFN-y induction (not shown),
in which no FcyR-a mRNA could be detected (see Fig. 3 A), suggesting that the
IgG2a monomeric receptor is separable from the FcyR-a moiety we describe here.
Third, IFN-y stimulation of peritoneal macrophages resulted in induction of an
IgG2a high-affinity receptor, which was not inhibited by 2AG2, yet FcyR-a mRNA
was not induced in those cells, further suggesting that FcyR-a is not a component
of a high-affinityIgG2areceptor. Finally, we can rule out the possibility that FcyR-(i
associates with FcyRa to form a high-affinity binding site, since J774a cells lack
FcyR-(3, yet possess constitutive and inducible IgG2a receptors. Although the data
presented here show that FcyR-a binds immune complexes andnot monomeric IgG,
we cannot rule out the possibility that some relationship exists between FcyR-a and
otheras yet unidentified proteins on macrophages that may altereither the specificity
or affinity of this receptor.
To address the functional roles of FcyR-a and Fcy-R, we have investigated the regu-
lation of these two genes within the context of macrophage activation. Using highly
purified mouse-IFN-y, we have shown that the FcyRa mRNA and protein are
specifically induced in RAW 264.7 andJ774a macrophage cell lines. The induction
is dramatic in both cell lines (25-fold in FcyR-a mRNA in J774a cells) and specific
for IFN-y, amongthe cytokines tested. Interestingly, the maximalinduction decreases1922 EXPRESSION OF MURINE FcyR GENES
in the continued presence of IFN-y after 16 h but does not return to baseline, even
after 50 h. Similar transient accumulation has been observed for other inducible
genes(42, 43), and results, in part, frompost-transcriptional mechanisms (44). Fur-
ther studies involving transcriptional and post-transcriptional stabilization of FcyRa
mRNA will be necessary to determine the mechanism of this transient induction.
Surface expression of FcyRa protein was induced with IFN-y on RAW andJ774a
cells as measured by increased levels ofthe 2AG2 epitope as well as increased levels
of a protein detected by FcyRa-specific anti-peptide sera. Although mAb 2AG2
recognizes both FcyRa and FcyR-a, FcyRa mRNA was not present or inducible
in these cells. Thesedata, in conjunction with the expression ofthe transfected FcyRa
molecule, shows that FcyRa bears a 2AG2 epitope. Functional ligand binding and
inhibition by 2AG2 on J774a cells confirms that FcyR-a is a functional low-affinity
binding IgG FcR on macrophages.
The genetic heterogeneity ofthe molecules bearing the 2AG2 epitope illustrates
the limitations of using an Ab to define the regulation of this family of receptors.
IFN-y induces the FcyR-a molecule and leads to increased expression ofthe 2AG2
epitope ofJ774a and RAW cells where FcyR-R expression is low or absent. How-
ever, thisinductionofthe 2AG2epitope isnotseenonperitoneal macrophages treated
with IFN-y, since the effect ofthis lymphokine is to down regulate FcyRa gene ex-
pression, leaving FcyR-a expression at highlevels. The net effect onperitoneal mac-
rophages is to decrease the 2.4G2-bearing molecules on these cells, while dramati-
cally altering the ratio ofFcyR-a and -a gene expression, which islikely to contribute
to their functional state.
Macrophage activation by IFN-y leads to the phagocytosis ofIgG-opsonized par-
ticles (12). When induced with IFN-y, RAW 264.7 andJ774a cells exhibit dramatic
increases in their ability to engulf IgG-opsonized particles. This correlates with the
induction ofFcyR-a mRNA, protein, and IgG immune complex-binding in these
cell lines. In cells such as P388D1 and resting peritoneal macrophages, which are
actively phagocytic in the absence ofIFN-y, FcyRa is already maximally expressed.
When perintoneal macrophages are induced with IFN-y, they not only continue
to produce FcyRa, but down regulate FcyRa mRNA accumulation. FcyRa, there-
fore, is coordinately induced with the appearance ofphagocytosis or maintained at
high levels in cells that are already phagocytic. It is likely that IFN-y induces a va-
riety of gene products that are involved in the ability of a cell to perform phagocy-
tosis. The inducibility ofFcyRa and the subsequent increased binding capacity of
a macrophage may not be sufficient alone to induce phagocytosis. Consistent with
this notion, although abundant rosetting was detected on untreated RAW orJ774a
cells, no phagocytosis was observed until IFN-y stimulation. It is likely that surface
bindingis not, in itself, sufficient to trigger phagocytosis in these macrophages lines,
and induction ofspecificproteins by IFN-y mediates this coupling to the cytoskeleton.
Conversely, mouse LtK- cells, a fibroblast cell line, transfected with FcyR-a or -a,
were not capable ofphagocytosis despite high levels of IgG-coated SRBC binding.
Therefore, the receptor itself may not be capable of mediating such an event. In
a cell that is competent for phagocytosis, however, FcyR-a may provide the neces-
sary coupling mechanism to mediatethiscomplex process. The contribution ofspecific
protein domains of FcyRa and the role of IFN-y-inducible components are cur-
rently under investigation to dissect the cellular machinery of phagocytosis.Summary
Ligand binding specificities oftwo cloned murine FcyRs (FcyR-a, FcyRR [9]) were
determined by gene transfer into FcyR negative cell lines. Both receptors were ex-
pressed as full-length molecules capable of IgG immune complex binding that was
inhibitable by the mAb 2AG2. The ligand binding profiles of these receptors were
indistinguishable whereby both bound immune-complexed mouse IgG1, IgG2a, and
IgG2b, but not IgG3. Neither receptor could bind monomeric IgG2a, indicating
these receptors to be low-affinity IgG Fc receptors.
Accumulation ofthe FcyR-a mRNA can be induced with murine IFN-y at a con-
centration of 200 U/ml in the macrophage-like cell lines RAW 264.7 and J774a.
The time course for induction indicates that the mRNA accumulation is transient
but does not return to the uninduced level even after 50 h of treatment. FcyR-p mRNA
was not induced by IFN-y, rather its expression was down modulated in mouse peri-
toneal macrophages. Both RAW and J774a cells lines exhibited increased receptor
levels after IFN-y stimulation as measured by 1211-2.4G2 and ligand binding. In the
absence of IFN-y, the RAW and J774a cell lines were minimally phagocytic, while
P388D1 cells were actively phagocytic. In the presence of IFN-y, however, RAW
264.7 andJ774a cells were induced to become actively phagocytic. Induction of FcyR-
a mRNA and protein by IFN-y may be part of the process by which macrophages
become activated to engulf antibody-coated particles.
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